Actionable news
All posts from Actionable news
Actionable news in BMY: BRISTOL-MYERS SQUIBB CO.,

Bristol-Myers says lung cancer drug failed to meet primary endpoint

Bristol-Myers Squibb (NYSE:BMY) -16.7% premarket after announcing that CheckMate -026, a Phase 3 trial investigating the use of Opdivo as monotherapy, did not meet its primary endpoint of...